Journal Mobile Options
Table of Contents
Vol. 19, No. 4, 2002
Issue release date: 2002

Mucin-Secreting Bile Duct Adenoma – Clinicopathological Resemblance to Intraductal Papillary Mucinous Tumor of the Pancreas

Oshikiri T. · Kashimura N. · Katanuma A. · Maguchi H. · Shinohara T. · Shimizu M. · Kondo S. · Katoh H.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

We describe a case of mucin-secreting biliary adenoma associated with obstructive jaundice due to mucin production. Duodenal endoscopy revealed mucin secretion through an enlarged papilla of Vater. On the cholangiogram, large filling defects caused by mucin were observed in the dilated bile duct. Granular and/or papillary mucosa was noted from the hilar to the common bile duct by using percutaneous transhepatic cholangioscopy. Biopsy specimens taken from the papillary mucosa revealed slightly papillary projection without any evidence of malignancy. This lesion was diagnosed as mucin-secreting superficial adenoma and pancreatoduodenectomy was performed according to the malignant behavior. Using a histologic examination of the specimen, pure adenoma was documented. Since the surgical margin was positive, radiation was added for the residual adenoma in the intrahepatic bile ducts. The patient has been well without any evidence of recurrence for 21 months since her operation. It is only recently that the term ‘intraductal papillary mucinous tumor (IPMT)’, which is accepted as a distinct disease entity of pancreas, has begun to be used for mucin-secreting bile duct tumor. This case also seemed to clinicopathologically resemble an IPMT of the pancreas.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Sakamoto E, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, Miyachi M, Uesaka K, Nimura Y: Treatment strategy for mucin-producing intrahepatic cholangiocarcinoma: Value of percutaneous transhepatic biliary drainage and cholangioscopy. World J Surg 1999;23:1038–1044.
  2. Wang YL, Lee SD, Lai KH, Wang SS, Lo KJ: Primary biliary cystic tumors of the liver. Am J Gastroenterol 1993;88:599–603.
  3. Styne P, Warren GH, Kumpe DA, Halgrimson C, Kern F Jr: Obstructive cholangitis secondary to mucus secreted by a solitary papillary bile duct tumor. Gastroenterology 1986;90:748–753.

    External Resources

  4. Shimizu M, Manabe T: Mucin-producing pancreatic tumors: Historical review of its nosological concept. Zentralbl Pathol 1994;140:211–223.
  5. Kloppel G, Solcia E, Longnecker DS: Histological typing of tumors of the exocrine pancreas; in World Health Organization International Histological Classification of Tumors, ed 2. Berlin, Springer, 1996, pp 11–20.
  6. Kim JH, Kim MH, Lee SK, Yoo KS, Park ET, Lim BC, Park HJ, Myung SJ, Seo DW, Min YI: Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor of the pancreas. Endoscopy 2000;32:389–393.
  7. Kokubo T, Itai Y, Ohtomo K, Itoh K, Kawauchi N, Minami M: Mucin-hypersecreting intrahepatic biliary neoplasms. Radiology 1988;168:609–614.

    External Resources

  8. Kim YS, Myung SJ, Lee SK, Kim MH: Role of percutaneous transhepatic cholangioscopy in biliary papillomatosis: Can it change treatment modality? Gastrointest Endosc 1998;47:563–564.
  9. Caroli J: Disease of the intrahepatic biliary tree. Clin Gastroenterol 1973;2:147–161.

    External Resources

  10. Padfield CJH, Ansell ID, Furness PN: Mucinous biliary papillomatosis: A tumor in need of wider recognition. Histopathology 1988;13:687–694.

    External Resources

  11. Lind DS, Adolph V, Parker GA: Mucinous biliary cystadenoma: A case report and review of the literature. J Surg Oncol 1992;51:207–210.
  12. Matsumoto S, Miyake H, Mori H: Case report: Biliary cystadenoma with mucin secretion mimicking a simple hepatic cyst. Clin Radiol 1997;52:316–318.
  13. Obara T, Maguchi H, Saitoh Y, Itoh A, Arisato S, Ashida T, Nishino N, Ura H, Namiki M: Mucin-producing tumor of the pancreas: Natural history and serial pancreatogram changes. Am J Gastroenterol 1993;88:564–569.
  14. Sadler TW: Langman’s Medical Embryology. Baltimore, Williams & Wilkins, 1985.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50